Gap ($GPS) reported in line third quarter adjusted

Gap ($GPS) reported in line third quarter adjusted earnings, while its revenues were slightly shy of estimates. The company lowered its full year adjusted earnings guidance below the consensus estimate. Edwards Lifesciences ($EW) announced its board has approved a 2-for-1 split of its outstanding common stock to be effected as a 100 percent stock dividend.